Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. (Q52184569)
Jump to navigation
Jump to search
scientific article published in September 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. |
scientific article published in September 1998 |
Statements
1 reference
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. (English)
1 reference
A M Senderowicz
1 reference
D Headlee
1 reference
S F Stinson
1 reference
R M Lush
1 reference
N Kalil
1 reference
L Villalba
1 reference
K Hill
1 reference
S M Steinberg
1 reference
W D Figg
1 reference
A Tompkins
1 reference
S G Arbuck
1 reference
E A Sausville
1 reference
1 September 1998
1 reference
16
1 reference
2986-2999
1 reference
9
1 reference
Identifiers
1 reference